CA2999614C - Park2 as epigenetic marker for the identification of immune cells, in particular monocytes - Google Patents

Park2 as epigenetic marker for the identification of immune cells, in particular monocytes Download PDF

Info

Publication number
CA2999614C
CA2999614C CA2999614A CA2999614A CA2999614C CA 2999614 C CA2999614 C CA 2999614C CA 2999614 A CA2999614 A CA 2999614A CA 2999614 A CA2999614 A CA 2999614A CA 2999614 C CA2999614 C CA 2999614C
Authority
CA
Canada
Prior art keywords
monocytes
methylation
cells
cpg
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2999614A
Other languages
English (en)
French (fr)
Other versions
CA2999614A1 (en
Inventor
Sven Olek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precision for Medicine GmbH
Original Assignee
Precision for Medicine GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Precision for Medicine GmbH filed Critical Precision for Medicine GmbH
Publication of CA2999614A1 publication Critical patent/CA2999614A1/en
Application granted granted Critical
Publication of CA2999614C publication Critical patent/CA2999614C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Mechanical Control Devices (AREA)
CA2999614A 2015-09-25 2016-09-22 Park2 as epigenetic marker for the identification of immune cells, in particular monocytes Active CA2999614C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1516975.8A GB201516975D0 (en) 2015-09-25 2015-09-25 PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes
GB1516975.8 2015-09-25
PCT/EP2016/072594 WO2017050925A1 (en) 2015-09-25 2016-09-22 Park2 as epigenetic marker for the identification of immune cells, in particular monocytes

Publications (2)

Publication Number Publication Date
CA2999614A1 CA2999614A1 (en) 2017-03-30
CA2999614C true CA2999614C (en) 2023-02-28

Family

ID=54544104

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2999614A Active CA2999614C (en) 2015-09-25 2016-09-22 Park2 as epigenetic marker for the identification of immune cells, in particular monocytes

Country Status (7)

Country Link
US (1) US11761041B2 (https=)
EP (1) EP3353319B1 (https=)
JP (1) JP2018529346A (https=)
CN (2) CN108026590B (https=)
CA (1) CA2999614C (https=)
GB (1) GB201516975D0 (https=)
WO (1) WO2017050925A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102017125013B4 (de) * 2017-10-25 2019-10-17 Epiontis Gmbh MCC als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere basophiler Granulozyten
DE102017125150B4 (de) * 2017-10-26 2019-10-10 Epiontis Gmbh Endosialin (CD248) als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere naïver CD8+ T-Zellen
DE102017125335B4 (de) 2017-10-27 2019-10-17 Epiontis Gmbh Amplikon-Region als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere nicht-klassischer Monozyten
HK1256212A2 (zh) * 2018-12-27 2019-09-13 汪恩光 拉动式的换挡传动系统及食物料理机
JPWO2022191293A1 (https=) * 2021-03-12 2022-09-15

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367012T3 (es) * 2006-02-28 2011-10-27 Charite-Universitätsmedizin Berlin Detección y control de calidad de linfocitos t reguladores a través del análisis de metilación del adn del gen foxp3.
CA2671270A1 (en) * 2006-12-29 2008-07-17 Asuragen, Inc. Mir-16 regulated genes and pathways as targets for therapeutic intervention
PL2248913T3 (pl) * 2009-04-28 2017-04-28 Epiontis Gmbh GNLY jako marker epigenetyczny do identyfikacji komórek naturalnej cytotoksyczności ekspresjonujących CD56
WO2011128820A2 (en) * 2010-04-16 2011-10-20 Koninklijke Philips Electronics N.V. Methods for the analysis of breast cancer disorders
WO2013033627A2 (en) * 2011-09-01 2013-03-07 The Regents Of The University Of California Diagnosis and treatment of arthritis using epigenetics
WO2013067451A2 (en) * 2011-11-04 2013-05-10 Population Diagnostics Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
JP6590790B2 (ja) * 2013-04-19 2019-10-16 エピオンティス ゲーエムベーハー 生体サンプルにおける定量的細胞組成を特定する方法

Also Published As

Publication number Publication date
HK1257582A1 (en) 2019-10-25
US11761041B2 (en) 2023-09-19
WO2017050925A1 (en) 2017-03-30
EP3353319A1 (en) 2018-08-01
CN108026590A (zh) 2018-05-11
JP2018529346A (ja) 2018-10-11
CN108026590B (zh) 2023-10-31
US20180216184A1 (en) 2018-08-02
CN211582764U (zh) 2020-09-29
EP3353319B1 (en) 2020-10-21
GB201516975D0 (en) 2015-11-11
CA2999614A1 (en) 2017-03-30

Similar Documents

Publication Publication Date Title
CA2999614C (en) Park2 as epigenetic marker for the identification of immune cells, in particular monocytes
US11643687B2 (en) LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
US11788141B2 (en) MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells
US11680294B2 (en) Amplicon region as epigenetic marker for the identification of non-classical monocytes
CA3080057A1 (en) Mcc as epigenetic marker for the identification of immune cells, in particular basophil granulocytes
US11976327B2 (en) ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs)
CA3080060C (en) Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells
EP3669003B1 (en) Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells
CA2999611C (en) Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells
HK1257582B (en) Park2 as epigenetic marker for the identification of immune cells, in particular monocytes
WO2019224014A1 (en) Cxcr3 as epigenetic marker for the identification of inflammatory immune cells, in particular cd8+ memory t cells

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190927

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240910

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240910

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240910

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 9TH ANNIV.) - STANDARD

Year of fee payment: 9

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250917

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250917